Thanks to Sector posting on the other thread regarding the companies' ramp up plan ( Pre Novartis ), they were targeting 10,000 COVID doses delivered within the first 6 months using existing methods.
A minimum rate of 20,000 doses per year minimum ( remember this includes the delay to actually achieve the ramp up, and I would expect post the ramp up 6 month period, the available doses would be higher........double if ramp up is linear).
20,000 doses, 10% Royalty would be $14 AUD, excluding all milestones.
$90 a share on COVID ARDS Authorization ?, page-49
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |